Valuation: Optigenex Inc.

Market Cap 19.94K 17.08K 15.98K 14.63K 27.45K 1.91M 27.81K 189K 73.62K 958K 74.85K 73.23K 3.17M P/E 2006 *
-
P/E 2007 -
Enterprise Value 8.95M 7.67M 7.18M 6.57M 12.33M 857M 12.49M 84.79M 33.07M 430M 33.62M 32.89M 1.42B EV / Sales 2006
20.5x
EV / Sales 2007 19.3x
Free-Float
21.27%
Yield 2006 *
-
Yield 2007 -
Manager TitleAgeSince
Chief Executive Officer 69 -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 35
+0.88%+6.38%+76.40%+126.87% 1,119B
+1.07%+3.80%+50.73%+64.25% 651B
+1.20%+6.21%+25.81%+80.15% 468B
+1.02%+5.77%+43.63%+43.06% 374B
+0.85%+4.07%+24.97%+41.00% 302B
+1.26%+6.81%+2.27%+13.65% 259B
+1.88%+5.81%+49.57%+70.71% 238B
+1.59%+2.09%-17.33%-53.85% 208B
+1.87%+5.61%+27.32%+89.67% 181B
Average +1.16%+5.17%+31.49%+52.83% 422.21B
Weighted average by Cap. +1.14%+5.40%+44.26%+72.42%

Financials

2006 2007
Net sales 301K 258K 241K 221K 414K 28.79M 420K 2.85M 1.11M 14.46M 1.13M 1.11M 47.84M 466K 399K 373K 342K 642K 44.58M 650K 4.41M 1.72M 22.4M 1.75M 1.71M 74.08M
Net income -7.36M -6.3M -5.9M -5.4M -10.13M -704M -10.26M -69.67M -27.17M -354M -27.63M -27.03M -1.17B -2.9M -2.48M -2.32M -2.13M -3.99M -277M -4.04M -27.44M -10.7M -139M -10.88M -10.64M -461M
Net Debt 6M 5.14M 4.81M 4.4M 8.26M 574M 8.37M 56.81M 22.15M 288M 22.53M 22.04M 954M 8.93M 7.65M 7.16M 6.55M 12.3M 855M 12.46M 84.6M 32.99M 429M 33.55M 32.82M 1.42B
Logo Optigenex Inc.
Optigenex Inc. is an applied sciences company. The Company is focused on providing solutions for healthy age management. Its ac-11 is the patented compound that helps the body to repair its own deoxyribonucleic acid (DNA). Its ac-11 is used in both dietary supplements and advanced cosmetics to repair skin damaged by overexposure to the sun, restore optimal cellular function, and promote healthy aging. The Company's technology helps the body’s natural ability to repair DNA; enhances the immune system by increasing the life cycle of white blood cells; repairs neural function damaged by overexposure to high decibel noise; helps to normalize the expression of NF-KB, thereby regulating the cellular response to systemic inflammation; maintains telomere length and integrity during the process of cellular mitosis, and increases production of natural collagen III.
Employees
-